Atrial Fibrillation Market by Type (Surgical [Maze Surgery and Catheter Ablation] and Non-Surgical [Electric Cardioversion, Pharmacological Drugs, Diagnostic Devices, Mapping and Recording Systems, Cardiac Monitors, Access Devices, and Left Atrial Appendage and Closure Devices]) - Global Opportunity Analysis and Industry Forecast, 2014-2022
Atrial fibrillation is of the most frequently occurred arrhythmia that causes problem with the rhythm of the heart (such as too slow or too fast heart beat). During atrial fibrillation, heart beats are irregular and it can be too slow or too fast as compared to the regular heartbeat. Atrial fibrillation can increase the rate of heart stroke, cause chest pain or even heart attack especially if the heart beat is too fast. During atrial fibrillation, both the chambers (upper and lower) beat irregularly, chaotically, and out of coordination of the heart. Shortness of breath, weakness, chest pain, dizziness, lightheadedness or fainting and heart palpitation are the common symptoms of atrial fibrillation. In addition, atrial fibrillation may lead to formation of blood clots in the heart, which may circulate to other organs. In atrial fibrillation, for altering the electrical system of heart, treatments such as medications and interventions are provided.
Atrial fibrillation market is in its emerging state as the prevalence of atrial fibrillation is growing rapidly along with the increase in aging population. According to American Heart Association, 33.5 million individuals (0.5% of the world’s population) were with atrial fibrillation in 2013. Also, technological advancement towards surgical devices for atrial fibrillation fuels the market growth. However, pitfalls such as stringent government policies, high cost of atrial fibrillation treatment, and dearth of skilled professionals and technicians hinders the market growth.
The world atrial fibrillation market has been segmented based on devices and region. Based on devices, the market is segmented into surgical devices and non-surgical devices. Surgical devices are further sub-classified into maze surgery and catheter ablation. Non-surgical devices are further sub-divided into electric cardioversion, diagnostic catheters, mapping and recording systems, cardiac monitors, access devices, left atrial appendage, and closure devices and intracardiac echocardiography (ICE) Systems. The market is analyzed on the basis of four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
The key strategies adopted are product launch, collaboration, and merger & acquisition. For instance, Abbott acquired Kalila Medical, Inc. (U.S.), which helped Abbott develop next generation technologies that are useful to treat cardiac disorders such as atrial fibrillation. Biosense Webster, Inc. acquired Coherex Medical, Inc. (U.S.), which helped Biosense Webster, Inc. to strengthen its medical devices product portfolio.
KEY MARKET BENEFITS:
By Devices
Atrial fibrillation market is in its emerging state as the prevalence of atrial fibrillation is growing rapidly along with the increase in aging population. According to American Heart Association, 33.5 million individuals (0.5% of the world’s population) were with atrial fibrillation in 2013. Also, technological advancement towards surgical devices for atrial fibrillation fuels the market growth. However, pitfalls such as stringent government policies, high cost of atrial fibrillation treatment, and dearth of skilled professionals and technicians hinders the market growth.
The world atrial fibrillation market has been segmented based on devices and region. Based on devices, the market is segmented into surgical devices and non-surgical devices. Surgical devices are further sub-classified into maze surgery and catheter ablation. Non-surgical devices are further sub-divided into electric cardioversion, diagnostic catheters, mapping and recording systems, cardiac monitors, access devices, left atrial appendage, and closure devices and intracardiac echocardiography (ICE) Systems. The market is analyzed on the basis of four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
The key strategies adopted are product launch, collaboration, and merger & acquisition. For instance, Abbott acquired Kalila Medical, Inc. (U.S.), which helped Abbott develop next generation technologies that are useful to treat cardiac disorders such as atrial fibrillation. Biosense Webster, Inc. acquired Coherex Medical, Inc. (U.S.), which helped Biosense Webster, Inc. to strengthen its medical devices product portfolio.
KEY MARKET BENEFITS:
- In-depth analysis of the market is conducted based on market estimations of the key segments for the period 2014-2022
- Comprehensive analysis of factors that drive and restrict the growth of the world atrial fibrillation market is provided in the report
- Exhaustive analysis of the world atrial fibrillation market by different segments helps understand the different aspects of atrial fibrillation that are currently used along with the variants that would gain prominence in the future
- Competitive intelligence of leading manufacturers and distributors of atrial fibrillation market interprets the competitive scenario across various geographies
- Key market players within the atrial fibrillation market are profiled in the report and their strategies are analyzed thoroughly, which predicts competitive outlook of the world market.
By Devices
- Surgical Devices
- Maze Surgery
- Catheter Ablation
- Radiofrequency Catheter Ablation
- Conventional RF Ablation Catheters
- Irrigated-tip RF Ablation Catheters
- Cryoablation
- Microwave Based Catheter Ablation
- Laser Based Catheter Ablation
- Navigational Advanced Mapping Accessories
- Non-Surgical Devices
- Electric Cardioversion
- Diagnostic Catheters
- Conventional Diagnostic Catheters
- Fixed Diagnostic Catheters
- Steerable Diagnostic Catheters
- Advanced Diagnostic Catheters
- Mapping and Recording Systems
- Cardiac Monitors
- Access Devices
- Left Atrial Appendage and Closure Devices
- Intracardiac Echocardiography (ICE) Systems
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- India
- China
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Egypt
- Israel
- South Africa
- Rest of LAMEA
- Abbott Laboratories
- Johnson & Johnson
- MicroPort Scientific Corporation
- Boston Scientific Corporation
- St. Jude Medical, Inc.
- Medtronic plc
- Biotronik SE & Co. KG
- Koninklijke Philips N.V.
- Siemens AG
- AtriCure Inc.
- Biosense Webster, Inc.
- CardioFocus, Inc.
- CathEffects Inc.
- CathRx Ltd.
- EndoPhotonix, Inc.
- Japan Lifeline Co.
- Osypka AG
- Pioneer Medical Devices AG
- GE Healthcare
- TZ Medical, Inc.
CHAPTER 1. INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2. EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3. MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.3. TOP WINNING STRATEGIES
3.4. PORTERS FIVE FORCES ANALYSIS
3.4.1. Bargaining power of suppliers
3.4.2. Bargaining power of buyers
3.4.3. Threat of new entrants
3.4.4. Competitive rivalry
3.4.5. Threat of substitutes
3.5. MARKET SHARE ANALYSIS, 2015
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Rising prevalence of atrial fibrillation in geriatric population
3.6.1.2. Technological advancements
3.6.1.3. Increasing preference of catheter ablation for cardiac arrhythmia treatment
3.6.2. Restraints
3.6.2.1. Dearth of skilled professionals
3.6.2.2. Unfavorable preference to pharmaceutical interventions (drugs) over AF treatment devices
3.6.3. Opportunities
3.6.3.1. Rising awareness of atrial fibrillation
3.6.3.2. Opportunities in emerging countries
CHAPTER 4. ATRIAL FIBRILLATION MARKET, BY DEVICES
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. SURGICAL DEVICES
4.2.1.1. Key market trends
4.2.1.2. Key growth factors and opportunities
4.2.2. Market size and forecast
4.2.2.1. MAZE surgery
4.2.2.2.Catheter ablation
4.3. NON-SURGICAL DEVICES
4.3.1. Key market trends
4.3.1.2. Key growth factors and opportunities
4.3.2. Market size and forecast
4.3.2.1. Electric cardioversion
4.3.2.2. Mapping and recording systems
4.3.2.3. Cardiac monitors
4.3.2.4. Access devices
4.3.2.5. Left Atrial Appendage (LAA) and closure devices
4.3.2.6. Intracardiac echocardiography (ICE) systems
CHAPTER 5. ATRIAL FIBRILLATION MARKET, BY REGION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. NORTH AMERICA
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast
5.3. EUROPE
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.3.1. Germany market size and forecast
5.3.3.2. France market size and forecast
5.3.3.3. U.K. market size and forecast
5.3.3.4. Italy market size and forecast
5.3.3.5. Spain market size and forecast
5.3.3.6. Rest of Europe market size and forecast
5.4. ASIA PACIFIC
5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.3.1. Japan market size and forecast
5.4.3.2. India market size and forecast
5.4.3.3. China market size and forecast
5.4.3.4. Australia market size and forecast
5.4.3.5. South Korea market size and forecast
5.4.3.6. Rest of Asia-Pacific market size and forecast
5.5. LAMEA
5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.3.1. Brazil market size and forecast
5.5.3.2. Argentina market size and forecast
5.5.3.3. Egypt market size and forecast
5.5.3.4. Israel market size and forecast
5.5.3.5. South Africa market size and forecast
5.5.3.6. Rest of LAMEA market size and forecast
CHAPTER 6. COMPANY PROFILES
6.1. ABBOTT LABORATORIES
6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Business performance
6.1.5. Key strategic moves & developments
6.2. JOHNSON & JOHNSON
6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Business performance
6.2.5. Key strategic moves & developments
6.3. ATRICURE, INC.
6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Business performance
6.3.5. Key strategic moves & developments
6.4. MICROPORT SCIENTIFIC CORPORATION
6.4.1. Company overview
6.4.2. Company Snapshot
6.4.3. Operating Business Segments
6.4.4. Business Performance
6.4.5. Key strategic moves & developments
6.5. BOSTON SCIENTIFIC CORPORATION
6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves & developments
6.6. ST. JUDE MEDICAL, INC.
6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. Key strategic moves & developments
6.7. MEDTRONIC PLC
6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves & developments
6.8. BIOTRONIK SE & CO. KG
6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Key strategic moves & developments
6.9. KONINKLIJKE PHILIPS N.V.
6.9.1. Company overview
6.9.2. Philips- SNAPSHOT
6.9.3. Operating business segments
6.9.4. Business performance
6.9.5. Key strategic moves and developments
6.10. SIEMENS AG
6.10.1. Company overview
6.10.2. Siemens Healthcare- SNAPSHOT
6.10.3. Operating business segments
6.10.4. Financial performance
6.10.5. Key strategic moves and developments
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2. EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3. MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.3. TOP WINNING STRATEGIES
3.4. PORTERS FIVE FORCES ANALYSIS
3.4.1. Bargaining power of suppliers
3.4.2. Bargaining power of buyers
3.4.3. Threat of new entrants
3.4.4. Competitive rivalry
3.4.5. Threat of substitutes
3.5. MARKET SHARE ANALYSIS, 2015
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Rising prevalence of atrial fibrillation in geriatric population
3.6.1.2. Technological advancements
3.6.1.3. Increasing preference of catheter ablation for cardiac arrhythmia treatment
3.6.2. Restraints
3.6.2.1. Dearth of skilled professionals
3.6.2.2. Unfavorable preference to pharmaceutical interventions (drugs) over AF treatment devices
3.6.3. Opportunities
3.6.3.1. Rising awareness of atrial fibrillation
3.6.3.2. Opportunities in emerging countries
CHAPTER 4. ATRIAL FIBRILLATION MARKET, BY DEVICES
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. SURGICAL DEVICES
4.2.1.1. Key market trends
4.2.1.2. Key growth factors and opportunities
4.2.2. Market size and forecast
4.2.2.1. MAZE surgery
4.2.2.2.Catheter ablation
4.3. NON-SURGICAL DEVICES
4.3.1. Key market trends
4.3.1.2. Key growth factors and opportunities
4.3.2. Market size and forecast
4.3.2.1. Electric cardioversion
4.3.2.2. Mapping and recording systems
4.3.2.3. Cardiac monitors
4.3.2.4. Access devices
4.3.2.5. Left Atrial Appendage (LAA) and closure devices
4.3.2.6. Intracardiac echocardiography (ICE) systems
CHAPTER 5. ATRIAL FIBRILLATION MARKET, BY REGION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. NORTH AMERICA
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast
5.3. EUROPE
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.3.1. Germany market size and forecast
5.3.3.2. France market size and forecast
5.3.3.3. U.K. market size and forecast
5.3.3.4. Italy market size and forecast
5.3.3.5. Spain market size and forecast
5.3.3.6. Rest of Europe market size and forecast
5.4. ASIA PACIFIC
5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.3.1. Japan market size and forecast
5.4.3.2. India market size and forecast
5.4.3.3. China market size and forecast
5.4.3.4. Australia market size and forecast
5.4.3.5. South Korea market size and forecast
5.4.3.6. Rest of Asia-Pacific market size and forecast
5.5. LAMEA
5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.3.1. Brazil market size and forecast
5.5.3.2. Argentina market size and forecast
5.5.3.3. Egypt market size and forecast
5.5.3.4. Israel market size and forecast
5.5.3.5. South Africa market size and forecast
5.5.3.6. Rest of LAMEA market size and forecast
CHAPTER 6. COMPANY PROFILES
6.1. ABBOTT LABORATORIES
6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Business performance
6.1.5. Key strategic moves & developments
6.2. JOHNSON & JOHNSON
6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Business performance
6.2.5. Key strategic moves & developments
6.3. ATRICURE, INC.
6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Business performance
6.3.5. Key strategic moves & developments
6.4. MICROPORT SCIENTIFIC CORPORATION
6.4.1. Company overview
6.4.2. Company Snapshot
6.4.3. Operating Business Segments
6.4.4. Business Performance
6.4.5. Key strategic moves & developments
6.5. BOSTON SCIENTIFIC CORPORATION
6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves & developments
6.6. ST. JUDE MEDICAL, INC.
6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. Key strategic moves & developments
6.7. MEDTRONIC PLC
6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves & developments
6.8. BIOTRONIK SE & CO. KG
6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Key strategic moves & developments
6.9. KONINKLIJKE PHILIPS N.V.
6.9.1. Company overview
6.9.2. Philips- SNAPSHOT
6.9.3. Operating business segments
6.9.4. Business performance
6.9.5. Key strategic moves and developments
6.10. SIEMENS AG
6.10.1. Company overview
6.10.2. Siemens Healthcare- SNAPSHOT
6.10.3. Operating business segments
6.10.4. Financial performance
6.10.5. Key strategic moves and developments
LIST OF TABLES
TABLE 1. WORLD ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022
TABLE 2. WORLD SURGICAL DEVICES ATRIAL FIBRILLATION MARKET, BY DEVICES TYPE ($MILLION), 2014-2022
TABLE 3. WORLD SURGICAL DEVICES ATRIAL FIBRILLATION MARKET, BY REGION ($MILLION), 2014-2022
TABLE 4. WORLD ATRIAL FIBRILLATION MARKET FOR CATHETER ABLATION ($MILLION), 2014-2022
TABLE 5. WORLD ATRIAL FIBRILLATION MARKET FOR RADIOFREQUENCY CATHETER ABLATION($MILLION), 2014-2022
TABLE 6. WORLD ATRIAL FIBRILLATION MARKET FOR NON-SURGICAL DEVICES, BY TYPE ($MILLION), 2014-2022
TABLE 7. WORLD ATRIAL FIBRILLATION MARKET FOR NON-SURGICAL DEVICES, BY REGION ($MILLION), 2014-2022
TABLE 8. WORLD ATRIAL FIBRILLATION MARKET FOR DIAGNOSTIC CATHETER ($MILLION), 2014-2022
TABLE 9. WORLD ATRIAL FIBRILLATION MARKET FOR CONVENTIONAL DIAGNOSTIC CATHETER ($MILLION), 2014-2022
TABLE 10. WORLD ATRIAL FIBRILLATION MARKET, BY REGION ($MILLION), 2014-2022
TABLE 11. NORTH AMERICA ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
TABLE 12. NORTH AMERICA ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022
TABLE 13. EUROPE ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
TABLE 14. EUROPE ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022
TABLE 15. ASIA PACIFIC ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
TABLE 16. ASIA PACIFIC ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022
TABLE 17. LAMEA ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
TABLE 18. LAMEA ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022
TABLE 19. ABBOTT: COMPANY SNAPSHOT
TABLE 20. ABBOTT: OPERATING SEGMENTS
TABLE 21. J&J: COMPANY SNAPSHOT
TABLE 22. J&J: OPERATING SEGMENTS
TABLE 23. ATRICURE, INC.: COMPANY SNAPSHOT
TABLE 24. ATRICURE: OPERATING SEGMENTS
TABLE 25. MICROPORT: COMPANY SNAPSHOT
TABLE 26. MICROPORT: OPERATING SEGMENTS
TABLE 27. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 28. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 29. ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 30. ST. JUDE MEDICAL: OPERATING SEGMENTS
TABLE 31. MEDTRONIC: COMPANY SNAPSHOT
TABLE 1. WORLD ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022
TABLE 2. WORLD SURGICAL DEVICES ATRIAL FIBRILLATION MARKET, BY DEVICES TYPE ($MILLION), 2014-2022
TABLE 3. WORLD SURGICAL DEVICES ATRIAL FIBRILLATION MARKET, BY REGION ($MILLION), 2014-2022
TABLE 4. WORLD ATRIAL FIBRILLATION MARKET FOR CATHETER ABLATION ($MILLION), 2014-2022
TABLE 5. WORLD ATRIAL FIBRILLATION MARKET FOR RADIOFREQUENCY CATHETER ABLATION($MILLION), 2014-2022
TABLE 6. WORLD ATRIAL FIBRILLATION MARKET FOR NON-SURGICAL DEVICES, BY TYPE ($MILLION), 2014-2022
TABLE 7. WORLD ATRIAL FIBRILLATION MARKET FOR NON-SURGICAL DEVICES, BY REGION ($MILLION), 2014-2022
TABLE 8. WORLD ATRIAL FIBRILLATION MARKET FOR DIAGNOSTIC CATHETER ($MILLION), 2014-2022
TABLE 9. WORLD ATRIAL FIBRILLATION MARKET FOR CONVENTIONAL DIAGNOSTIC CATHETER ($MILLION), 2014-2022
TABLE 10. WORLD ATRIAL FIBRILLATION MARKET, BY REGION ($MILLION), 2014-2022
TABLE 11. NORTH AMERICA ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
TABLE 12. NORTH AMERICA ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022
TABLE 13. EUROPE ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
TABLE 14. EUROPE ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022
TABLE 15. ASIA PACIFIC ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
TABLE 16. ASIA PACIFIC ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022
TABLE 17. LAMEA ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
TABLE 18. LAMEA ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022
TABLE 19. ABBOTT: COMPANY SNAPSHOT
TABLE 20. ABBOTT: OPERATING SEGMENTS
TABLE 21. J&J: COMPANY SNAPSHOT
TABLE 22. J&J: OPERATING SEGMENTS
TABLE 23. ATRICURE, INC.: COMPANY SNAPSHOT
TABLE 24. ATRICURE: OPERATING SEGMENTS
TABLE 25. MICROPORT: COMPANY SNAPSHOT
TABLE 26. MICROPORT: OPERATING SEGMENTS
TABLE 27. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 28. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 29. ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 30. ST. JUDE MEDICAL: OPERATING SEGMENTS
TABLE 31. MEDTRONIC: COMPANY SNAPSHOT
LIST OF FIGURES
FIGURE 1. ATRIAL FIBRILLATION MARKET SEGMENTATION
FIGURE 2. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2012 - 2016)
FIGURE 3. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 4. PORTERS FIVE FORCES ANALYSIS
FIGURE 5. MARKET SHARE ANALYSIS, 2015
FIGURE 6. TOP IMPACTING FACTORS: WORLD ATRIAL FIBRILLATION MARKET
FIGURE 7. PREVALENCE OF ATRIAL FIBRILLATION BY AGE, 2012
FIGURE 8. WORLD ATRIAL FIBRILLATION MARKET FOR MAZE SURGERY ($MILLION), 2014-2022
FIGURE 9. WORLD ATRIAL FIBRILLATION MARKET FOR CRYOABLATION ($MILLION), 2014-2022
FIGURE 10. WORLD ATRIAL FIBRILLATION MARKET FOR MICROWAVE BASED CATHETER ABLATION ($MILLION), 2014-2022
FIGURE 11. WORLD ATRIAL FIBRILLATION MARKET FOR LASER BASED CATHETER ABLATION ($MILLION), 2014-2022
FIGURE 12. WORLD ATRIAL FIBRILLATION MARKET FOR NAVIGATIONAL ADVANCED MAPPING ACCESSORIES ($MILLION), 2014-2022
FIGURE 13. WORLD ATRIAL FIBRILLATION MARKET FOR CONVENTIONAL RADIOFREQUENCY CATHETER ABLATION ($MILLION), 2014-2022
FIGURE 14. WORLD ATRIAL FIBRILLATION MARKET FOR IRRIGATED-TIP RADIOFREQUENCY CATHETER ABLATION ($MILLION), 2014-2022
FIGURE 15. WORLD ATRIAL FIBRILLATION FOR ELECTRIC CARDIOVERSION ($MILLION), 2014-2022
FIGURE 16. WORLD ATRIAL FIBRILLATION MARKET FOR FIXED DIAGNOSTIC CATHETERS ($MILLION), 2014-2022
FIGURE 17. WORLD ATRIAL FIBRILLATION MARKET FOR STEERABLE DIAGNOSTIC CATHETERS ($MILLION), 2014-2022
FIGURE 18. WORLD ATRIAL FIBRILLATION MARKET FOR ADVANCED DIAGNOSTIC CATHETERS ($MILLION), 2014-2022
FIGURE 19. WORLD ATRIAL FIBRILLATION MARKET FOR MAPPING AND RECORDING SYSTEMS ($MILLION), 2014-2022
FIGURE 20. WORLD ATRIAL FIBRILLATION MARKET FOR CARDIAC MONITORS ($MILLION), 2014-2022
FIGURE 21. WORLD ATRIAL FIBRILLATION MARKET FOR ACCESS DEVICES ($MILLION), 2014-2022
FIGURE 22. WORLD ATRIAL FIBRILLATION MARKET FOR LEFT ATRIAL APPENDAGE AND CLOSURE DEVICES ($MILLION), 2014-2022
FIGURE 23. WORLD ATRIAL FIBRILLATION MARKET FOR INTRACARDIAC ECHOCARDIOGRAPHY (ICE) SYSTEMS ($MILLION), 2014-2022
FIGURE 24. U.S. ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 25. CANADA ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 26. MEXICO ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 27. GERMANY: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 28. FRANCE: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 29. U.K.: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 30. ITALY: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 31. SPAIN: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 32. REST OF EUROPE: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 33. JAPAN: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 34. INDIA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 35. CHINA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 36. AUSTRALIA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 37. SOUTH KOREA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 38. REST OF ASIA-PACIFIC: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 39. BRAZIL: ATRIAL FIBRILLATION DEVICES MARKET ($MILLION), 2014-2022
FIGURE 40. ARGENTINA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 41. EGYPT: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 42. ISRAEL: ATRIAL FIBRILLATION DEVICES MARKET ($MILLION), 2014-2022
FIGURE 43. SOUTH AFRICA: ATRIAL FIBRILLATION DEVICES MARKET ($MILLION), 2014-2022
FIGURE 44. REST OF LAMEA: ATRIAL FIBRILLATION DEVICES MARKET ($MILLION), 2014-2022
FIGURE 45. ABBOTT: NET SALES ($MILLION), 2013-2015
FIGURE 46. ABBOTT: NET SALES, BY BUSINESS SEGMENT (%), 2015
FIGURE 47. J&J: NET SALES, BY BUSINESS SEGMENT (%), 2015
FIGURE 48. J&J: NET SALES, BY REGION (%), 2015
FIGURE 49. J&J: STRATEGY SHARE (%), 2014-2015
FIGURE 50. ATRICURE: NET SALES ($MILLION), 2013-2015
FIGURE 51. ATRICURE: NET SALES, BY BUSINESS SEGMENT (%), 2015
FIGURE 52. ATRICURE: NET SALES, BY REGION (%), 2015
FIGURE 53. ATRICURE: STRATEGY SHARE (%), 2013-2016
FIGURE 54. MICROPORT: NET SALES ($MILLION), 2013-2015
FIGURE 55. MICROPORT: NET SALES, BY PRINCIPAL PRODUCT CATEGORY (%), 2015
FIGURE 56. MICROPORT: NET SALES, BY REGION (%), 2015
FIGURE 57. MICROPORT: STRATEGY SHARE (%), 2013- 2015
FIGURE 58. BOSTON SCIENTIFIC: NET SALES ($MILLION), 2013-2015
FIGURE 59. BOSTON SCIENTIFIC: NET SALES, BY BUSINESS SEGMENT (%), 2015
FIGURE 60. BOSTON SCIENTIFIC: RHYTHM MANAGEMENT NET SALES, BY SUB-SEGMENT (%), 2015
FIGURE 61. BOSTON SCIENTIFIC: NET SALES, BY REGION (%), 2015
FIGURE 62. BOSTON SCIENTIFIC: STRATEGY SHARE (%), 2013-2016
FIGURE 63. ST. JUDE MEDICAL: NET SALES ($MILLION), 2013-2015
FIGURE 64. ST. JUDE MEDICAL: NET SALES, BY PRODUCT CATEGORY (%), 2015
FIGURE 65. ST. JUDE MEDICAL: NET SALES, BY REGION (%), 2015
FIGURE 66. ST. JUDE MEDICAL: STRATEGY SHARE (%), 2014-2016
FIGURE 67. MEDTRONIC: OPERATING SEGMENTS
FIGURE 68. MEDTRONIC: NET SALES ($MILLION), 2014-2016
FIGURE 69. MEDTRONIC: NET SALES, BY SEGMENT (%), 2016
FIGURE 70. MEDTRONIC: CARDIAC AND VASCULAR GROUP NET SALES, BY SUB-SEGMENT (%), 2016
FIGURE 71. MEDTRONIC: NET SALES, BY REGION (%), 2016
FIGURE 72. MEDTRONIC: STRATEGY SHARE (%), 2014- 2016
FIGURE 73. BIOTRONIK: COMPANY SNAPSHOT
FIGURE 74. BIOTRONIK: OPERATING SEGMENTS
FIGURE 75. BIOTRONIK: STRATEGY SHARE (%), 2013-2016
FIGURE 76. PHILIPS: COMPANY SNAPSHOT
FIGURE 77. PHILIPS- OPERATING SEGMENTS
FIGURE 78. PHILIPS-NET SALES ($MILLION), 2013-2015
FIGURE 79. PHILIPS- NET SALES, BY SEGMENT (%), 2015
FIGURE 80. PHILIPS- NET SALES, BY REGION (%), 2015
FIGURE 81. PHILLIPS- STRATEGY SHARE (%), 2015-2016
FIGURE 82. SIEMENS-COMPANY SNAPSHOT
FIGURE 83. SIEMENS: OPERATING SEGMENTS
FIGURE 84. SEIMENS: NET SALES ($MILLION), 2013-2015
FIGURE 85. SEIMENS: NET SALES, BY SEGMENT (%), 2015
FIGURE 86. SEIMENS- NET SALES, BY REGION (%), 2015
FIGURE 1. ATRIAL FIBRILLATION MARKET SEGMENTATION
FIGURE 2. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2012 - 2016)
FIGURE 3. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 4. PORTERS FIVE FORCES ANALYSIS
FIGURE 5. MARKET SHARE ANALYSIS, 2015
FIGURE 6. TOP IMPACTING FACTORS: WORLD ATRIAL FIBRILLATION MARKET
FIGURE 7. PREVALENCE OF ATRIAL FIBRILLATION BY AGE, 2012
FIGURE 8. WORLD ATRIAL FIBRILLATION MARKET FOR MAZE SURGERY ($MILLION), 2014-2022
FIGURE 9. WORLD ATRIAL FIBRILLATION MARKET FOR CRYOABLATION ($MILLION), 2014-2022
FIGURE 10. WORLD ATRIAL FIBRILLATION MARKET FOR MICROWAVE BASED CATHETER ABLATION ($MILLION), 2014-2022
FIGURE 11. WORLD ATRIAL FIBRILLATION MARKET FOR LASER BASED CATHETER ABLATION ($MILLION), 2014-2022
FIGURE 12. WORLD ATRIAL FIBRILLATION MARKET FOR NAVIGATIONAL ADVANCED MAPPING ACCESSORIES ($MILLION), 2014-2022
FIGURE 13. WORLD ATRIAL FIBRILLATION MARKET FOR CONVENTIONAL RADIOFREQUENCY CATHETER ABLATION ($MILLION), 2014-2022
FIGURE 14. WORLD ATRIAL FIBRILLATION MARKET FOR IRRIGATED-TIP RADIOFREQUENCY CATHETER ABLATION ($MILLION), 2014-2022
FIGURE 15. WORLD ATRIAL FIBRILLATION FOR ELECTRIC CARDIOVERSION ($MILLION), 2014-2022
FIGURE 16. WORLD ATRIAL FIBRILLATION MARKET FOR FIXED DIAGNOSTIC CATHETERS ($MILLION), 2014-2022
FIGURE 17. WORLD ATRIAL FIBRILLATION MARKET FOR STEERABLE DIAGNOSTIC CATHETERS ($MILLION), 2014-2022
FIGURE 18. WORLD ATRIAL FIBRILLATION MARKET FOR ADVANCED DIAGNOSTIC CATHETERS ($MILLION), 2014-2022
FIGURE 19. WORLD ATRIAL FIBRILLATION MARKET FOR MAPPING AND RECORDING SYSTEMS ($MILLION), 2014-2022
FIGURE 20. WORLD ATRIAL FIBRILLATION MARKET FOR CARDIAC MONITORS ($MILLION), 2014-2022
FIGURE 21. WORLD ATRIAL FIBRILLATION MARKET FOR ACCESS DEVICES ($MILLION), 2014-2022
FIGURE 22. WORLD ATRIAL FIBRILLATION MARKET FOR LEFT ATRIAL APPENDAGE AND CLOSURE DEVICES ($MILLION), 2014-2022
FIGURE 23. WORLD ATRIAL FIBRILLATION MARKET FOR INTRACARDIAC ECHOCARDIOGRAPHY (ICE) SYSTEMS ($MILLION), 2014-2022
FIGURE 24. U.S. ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 25. CANADA ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 26. MEXICO ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 27. GERMANY: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 28. FRANCE: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 29. U.K.: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 30. ITALY: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 31. SPAIN: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 32. REST OF EUROPE: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 33. JAPAN: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 34. INDIA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 35. CHINA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 36. AUSTRALIA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 37. SOUTH KOREA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 38. REST OF ASIA-PACIFIC: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 39. BRAZIL: ATRIAL FIBRILLATION DEVICES MARKET ($MILLION), 2014-2022
FIGURE 40. ARGENTINA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 41. EGYPT: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 42. ISRAEL: ATRIAL FIBRILLATION DEVICES MARKET ($MILLION), 2014-2022
FIGURE 43. SOUTH AFRICA: ATRIAL FIBRILLATION DEVICES MARKET ($MILLION), 2014-2022
FIGURE 44. REST OF LAMEA: ATRIAL FIBRILLATION DEVICES MARKET ($MILLION), 2014-2022
FIGURE 45. ABBOTT: NET SALES ($MILLION), 2013-2015
FIGURE 46. ABBOTT: NET SALES, BY BUSINESS SEGMENT (%), 2015
FIGURE 47. J&J: NET SALES, BY BUSINESS SEGMENT (%), 2015
FIGURE 48. J&J: NET SALES, BY REGION (%), 2015
FIGURE 49. J&J: STRATEGY SHARE (%), 2014-2015
FIGURE 50. ATRICURE: NET SALES ($MILLION), 2013-2015
FIGURE 51. ATRICURE: NET SALES, BY BUSINESS SEGMENT (%), 2015
FIGURE 52. ATRICURE: NET SALES, BY REGION (%), 2015
FIGURE 53. ATRICURE: STRATEGY SHARE (%), 2013-2016
FIGURE 54. MICROPORT: NET SALES ($MILLION), 2013-2015
FIGURE 55. MICROPORT: NET SALES, BY PRINCIPAL PRODUCT CATEGORY (%), 2015
FIGURE 56. MICROPORT: NET SALES, BY REGION (%), 2015
FIGURE 57. MICROPORT: STRATEGY SHARE (%), 2013- 2015
FIGURE 58. BOSTON SCIENTIFIC: NET SALES ($MILLION), 2013-2015
FIGURE 59. BOSTON SCIENTIFIC: NET SALES, BY BUSINESS SEGMENT (%), 2015
FIGURE 60. BOSTON SCIENTIFIC: RHYTHM MANAGEMENT NET SALES, BY SUB-SEGMENT (%), 2015
FIGURE 61. BOSTON SCIENTIFIC: NET SALES, BY REGION (%), 2015
FIGURE 62. BOSTON SCIENTIFIC: STRATEGY SHARE (%), 2013-2016
FIGURE 63. ST. JUDE MEDICAL: NET SALES ($MILLION), 2013-2015
FIGURE 64. ST. JUDE MEDICAL: NET SALES, BY PRODUCT CATEGORY (%), 2015
FIGURE 65. ST. JUDE MEDICAL: NET SALES, BY REGION (%), 2015
FIGURE 66. ST. JUDE MEDICAL: STRATEGY SHARE (%), 2014-2016
FIGURE 67. MEDTRONIC: OPERATING SEGMENTS
FIGURE 68. MEDTRONIC: NET SALES ($MILLION), 2014-2016
FIGURE 69. MEDTRONIC: NET SALES, BY SEGMENT (%), 2016
FIGURE 70. MEDTRONIC: CARDIAC AND VASCULAR GROUP NET SALES, BY SUB-SEGMENT (%), 2016
FIGURE 71. MEDTRONIC: NET SALES, BY REGION (%), 2016
FIGURE 72. MEDTRONIC: STRATEGY SHARE (%), 2014- 2016
FIGURE 73. BIOTRONIK: COMPANY SNAPSHOT
FIGURE 74. BIOTRONIK: OPERATING SEGMENTS
FIGURE 75. BIOTRONIK: STRATEGY SHARE (%), 2013-2016
FIGURE 76. PHILIPS: COMPANY SNAPSHOT
FIGURE 77. PHILIPS- OPERATING SEGMENTS
FIGURE 78. PHILIPS-NET SALES ($MILLION), 2013-2015
FIGURE 79. PHILIPS- NET SALES, BY SEGMENT (%), 2015
FIGURE 80. PHILIPS- NET SALES, BY REGION (%), 2015
FIGURE 81. PHILLIPS- STRATEGY SHARE (%), 2015-2016
FIGURE 82. SIEMENS-COMPANY SNAPSHOT
FIGURE 83. SIEMENS: OPERATING SEGMENTS
FIGURE 84. SEIMENS: NET SALES ($MILLION), 2013-2015
FIGURE 85. SEIMENS: NET SALES, BY SEGMENT (%), 2015
FIGURE 86. SEIMENS- NET SALES, BY REGION (%), 2015
